Methylation Patterns of Rb1 and Casp-8 Promoters and Their Impact on Their Expression in Bladder Cancer

Aberrant methylation of the promoter CpG island of human genes is an alternative gene inactivation mechanisms that contributes to the carcinogenesis of human tumors. We tried to determine the methylation status and its impact on the expression of two tumor related genes Casp-8 and Rb1 in 103 bladder tumor tissues and 48 control paraffin-embedded tissues by using MSP-PCR and SQRT-PCR. Of the patients, 19.4% for Casp-8 and 28.2% for Rb1 showed methylation in bladder cancer. There were significant differences between patients and healthy controls in methylation of Rb1 (p = 0.001) and Casp-8 (p = 0.008) and especially when both genes methylated (p = 0.004). Methylation of Casp-8 has mostly been taken places in patients with age >60 years (p = 0.013) whereas methylation of Rb1 has taken place in age >60 (p = 0.018) as well as in patients age <60 (p = 0.027). Patients with methylated of both genes with stage T2 showed an increasing risk of 4.75 fold (95% CI = 2.87–7.85, p = 0.00) and for stage T3, 23.50 fold (95% CI = 6.05–91.21, p = 0.00) of bladder cancer. Smoking showed a high significant effect on methylation (p = 0.00 in compare to non-smoker patients), especially in those with pack-years more than 44.7 (OR = 3.53, 95% CI = 1.69–7.35, p = 0.001). The risk of bladder cancer was marginally associated in drinker patients (OR = 1.78, 95% CI = 1.42–2.24, p = 0.010) featuring both genes methylated, especially in those patients consumed alcohol units>30 per week (OR = 4.57, 95% CI = 2.38–8.80, p = 0.000). Significant reduction in expression has been detected in patients with methylated Rb1 (p = 0.00) and Casp-8 (p = 0.03). These results suggest that age, smoking and drinking will increase the probability of methylation of these genes and consequently increased risk of developing of bladder cancer to higher stages of disease. Interestingly, it has been deduced that methylation by itself maybe significantly have a role on reducing the expression ofRb1, but it seems that methylation along with risk factors lead to decrease the expression of Casp-8. Methylation of Rb1 can be considered as one of prognosis indicator for progression and development bladder cancer.

[1]  N. Davidson,et al.  DNA methylation in breast cancer. , 2001, Endocrine-related cancer.

[2]  A. Poustka,et al.  Assignment of CASP81 to human chromosome band 2q33→q34 and Casp82 to the murine syntenic region on chromosome 1B-proximal C by in situ hybridization , 1998, Cytogenetic and Genome Research.

[3]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[4]  Walter Doerfler,et al.  DNA methylation : basic mechanisms , 2006 .

[5]  K. To,et al.  Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  E. Messing,et al.  Molecular mechanisms and pathways in bladder cancer development and progression. , 2000, Cancer control : journal of the Moffitt Cancer Center.

[7]  Ram H Datar,et al.  Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B. Horsthemke,et al.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma , 1989, Human Genetics.

[9]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[10]  Ishtiaq Rehman,et al.  Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Walter G. Gunn.  Cancer: Principles and Practice of Oncology , 1982 .

[12]  M. Volm,et al.  Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB‐1) in childhood acute lymphoblastic leukaemia , 1996, British journal of haematology.

[13]  S. Scherer,et al.  Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2. , 2001, Genomics.

[14]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[15]  J. Gutmann,et al.  Apoptosis: an introduction for the endodontist. , 2003, International endodontic journal.

[16]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[17]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[18]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[19]  J. Minna,et al.  Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification , 2002, Oncogene.

[20]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[21]  Susan J Clark,et al.  DNA methylation and gene silencing in cancer: which is the guilty party? , 2002, Oncogene.

[22]  M. Day,et al.  Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. , 2005, Cancer research.

[23]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[24]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[25]  P. Katsel,et al.  On the etiology of Crohn disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[27]  J. Schlesselman,et al.  Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. , 2004, Oncology reports.

[28]  E. Hara,et al.  Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways , 2006, The British journal of dermatology.

[29]  M. Nistal,et al.  Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma , 2006, BMC Cancer.

[30]  Bruce A. Roe,et al.  DNA Isolation and Sequencing , 1996 .

[31]  Hui-Juan Yang,et al.  Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data , 2006, BMC Cancer.

[32]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[33]  M. Alonso,et al.  Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. , 2003, Oncology reports.

[34]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[35]  L. Kopelovich,et al.  The epigenome as a target for cancer chemoprevention. , 2003, Journal of the National Cancer Institute.

[36]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[37]  C. Plass,et al.  Methylation matters , 2001, Journal of medical genetics.

[38]  S. Groshen,et al.  Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. , 1998, Cancer research.

[39]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Laird,et al.  Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .

[41]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[42]  C. Pratt,et al.  St. Jude Children's Research Hospital. , 1997, Pediatric hematology and oncology.

[43]  Denis Bouchard,et al.  Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. , 2003, Genes & development.

[44]  S. Clark,et al.  Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. , 1997, Cancer research.